NovoEight Prices, Coupons and Patient Assistance Programs
NovoEight (antihemophilic factor) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hemophilia A.
NovoEight Prices
The cost for NovoEight intravenous powder for injection recombinant is around $12 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This NovoEight price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Intravenous Powder For Injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $11.53 | $11.53 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
NovoEight Coupons and Rebates
NovoEight offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Novoeight Co-pay Assistance Program: Eligible commercially insured patients may pay as little as $0 per fill and may save up to $12,000 per calendar year; for additional information contact the program at 844-668-6732.
| Applies to: | Novoeight |
| Number of uses: | 12 times within calendar year |
Novoeight Free Trial Prescription Program: Eligible patients may receive a trial prescription of up to 6 doses; for additional information contact the program at 844-668-6732.
| Applies to: | Novoeight |
| Number of uses: | 6 times |
Patient Assistance Programs for NovoEight
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Novoeight (antihemophilic factor recombinant) Injection; IV Lyophilized powder
Provider: NovoSecure
Elligibility requirements:- Must be uninsured
- At or below 400% of FPL
- Medically appropriate condition/diagnosis
- The patient must be a US citizen or legal resident.
- Free Trial Program: Contact Program for details
Applicable drugs:
- Novoeight (antihemophilic factor recombinant) Injection; IV Lyophilized powder
More about NovoEight (antihemophilic factor)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: miscellaneous coagulation modifiers
- FDA Approval History
Consumer resources
Other brands: Recombinate, Eloctate, Advate, Jivi, ... +14 more
